Foundry Partners’s Nu Skin NUS Stock Holding History

Foundry Partners’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-140,101	Closed	-$7.94M	–	381
2021 Q2	$7.94M	Sell	140,101 -4,336	-3%	-$247K	0.27%	139
2021 Q1	$7.64M	Buy	+144,437	New	+$7.87M	0.25%	132

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Foundry Partners's NUS Position: Q3 2021 in Review

Foundry Partners sold out of Nu Skin (NUS) in Q3 2021, closing a stake of 140,101 shares — an estimated $7.94M sold.

Foundry Partners first reported a position in NUS in Q1 2021 and held it in 2 quarters. The position peaked at $7.94M in Q2 2021. 246 funds tracked by Wall St. Rank hold NUS as of Q3 2021.

Foundry Partners reported no remaining Nu Skin position as of Q3 2021 after selling out during the quarter.
Foundry Partners sold 140,101 Nu Skin shares in Q3 2021, an estimated $7.94M.
Foundry Partners first reported a position in Nu Skin in Q1 2021 and held it in 2 quarters.
Foundry Partners's Nu Skin position peaked at $7.94M in Q2 2021.
246 funds tracked by Wall St. Rank held Nu Skin as of Q3 2021.

Based on Foundry Partners's 13F filing for Q3 2021, filed 14 Oct 2021.